Lycosome drug delivery

Lycotec has developed new liver-targeting delivery technology for orally administered drugs, vitamins, and other bioactive molecules.

This technology could benefit those drugs which target liver-specific biochemical pathways, for example statins (click for more information).

Lycotec technology promotes the selective delivery of drug molecules to the liver, consequently reducing their presence and hence side effects in extra-hepatic tissues.

The technology can be applied for other small molecules as well as for peptides and some

proteins – pharmacokinetic and pharmacodynamic data are available.

Imperox© – anti-inflammatory properties of metabolites produced by Penicillium roqueforti,Penicillium camemberti and some other food fungi
(click for more information)